Suffering in long-term cancer survivors: An evaluation of the PRISM-R2 in a population-based cohort
Suffering in long-term cancer survivors: An evaluation of the PRISM-R2 in a population-based cohort
复制标题
DOI：
10.1007/s11136-011-9911-x
复制
发表时间：
2011-12-01
影响因子：
3.5
通讯作者：
Mols, Floortje
中科院分区：
文献类型：
--
作者：
Lehmann, Vicky;Oerlemans, Simone;Mols, Floortje
疾病图示和自我测量修订版2（PRISM-R2）已被开发为评估痛苦的通用措施。本研究的目的是评估这种工具的能力，以确定长期癌症幸存者的痛苦，谁可能需要额外的支持。1299癌症幸存者完成了PRISM-R2，健康调查简表（SF-36），和生活质量癌症幸存者问卷（QoL-CS）。PRISM-R2区分自我疾病分离（SIS）和疾病感知测量（IPM），这两个测量方面的痛苦。112（9%）癌症幸存者报告高痛苦根据IPM。与报告较少痛苦的人相比，这组人在诊断时癌症分期较高，癌症复发率较高，合并症较多，受教育程度较低。PRISM-R2可以解释SF-36和QoL-CS心理方面的大量变异（10-14%）。IPM还区分高和低健康状态之间的统计学和临床显着的PRISM-R2被证明是能够区分个人之间的良好和恶化的生活质量水平。建议进一步评估其有效性和筛选潜力。
The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2) has been developed as generic measure to assess suffering. The aim of this study was to evaluate the ability of this instrument to identify long-term cancer survivors with high levels of suffering who may need additional support.1299 cancer survivors completed the PRISM-R2, the Short Form Health Survey (SF-36), and the Quality of Life-Cancer Survivors questionnaire (QoL-CS). The PRISM-R2 distinguishes between the Self-Illness Separation (SIS) and Illness Perception Measure (IPM), both measuring aspects of suffering.112 (9%) cancer survivors reported high suffering according to IPM. This group had a higher cancer stage at diagnosis, more cancer recurrences, more comorbidities, and were lower educated compared to people reporting less suffering. The PRISM-R2 could explain substantial amounts of variance (10-14%) in the psychological aspects of the SF-36 and QoL-CS. The IPM also discriminated statistically and clinically significant between high- and low-health status.The PRISM-R2 proved to be able to discriminate between individuals with good and deteriorated levels of QoL. Further evaluation of its validity and screening potential is recommended.